Different mechanisms may operate in therapies for AIDP and multifocal motor neuropathy.
Tanaka
M
M
D003520:Cyclophosphamide / Q000627:therapeutic use*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D016472:Motor Neuron Disease / Q000503:physiopathology / Q000628:therapy*; D010956:Plasmapheresis; D011129:Polyradiculoneuropathy / Q000503:physiopathology / Q000628:therapy*; D011241:Prednisone / Q000627:therapeutic use*
D016756:Immunoglobulins, Intravenous; D003520:Cyclophosphamide; D011241:Prednisone